News

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...
With Wegovy in its portfolio, Novo Nordisk is a very good bet to continue being a winner. As it's currently considered something of an underdog, with its stock priced accordingly, it's also trading at ...
Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.
Lakers fans held their breath as Luka Doncic suffered a scary fall in Game 5 against the Timberwolves, clutching his lower ...
Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug Wegovy. The pharmaceutical company announced it would ...